Is Alice deterring US patent case filings?
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Is Alice deterring US patent case filings?

Patent cases filings were down 40% last month compared with September 2013, according to data released this week by Lex Machina

lex20machina20patent20filings1.jpg


According to a Lex Machina blog post, plaintiffs filed 329 new federal patent cases in September 2014, down from 549 cases filed in the same month last year.

This does not seem a one-month anomaly. Filings over the past five months have dwindled after a reaching a record high in April 2014 (one week in April saw an unusually large number of filings – 199 – which appeared to be a result of non-practicing entities trying to pre-empt a proposed amendment to patent reform).

Since 2011, new filings have generally fallen during the summer and increased towards the end of the year. But Lex Machina reports that filings this year have not so far shown any signs of bouncing back upwards. Comparisons of corresponding months in 2013 and 2014 show lower monthly totals for 2014 since May.

lex20machina20patent20filings2.jpg



The reason? The Supreme Court’s decision in Alice v CLS Bank on June 19 appears to be deterring filing. Mark Lemley, law professor at Stanford and patent litigator at Durie Tangri, is in no doubt this is the case. He believes more patentees are deciding not to file suit following the Alice decision.

Alice made clear that merely implementing an abstract idea on a computer is not patentable. Since then, courts have been busy invalidating software patents that fall foul of this, such as one for a bingo game on a computer.

“In the past two months, we’ve seen over a dozen decisions invalidating software and business method patents on the basis of Alice,” Lemley said in the Lex Machina blog post. “That’s a pretty strong deterrent to software plaintiffs whose patent isn’t directed to specific new computer technology.”

This explanation seems reasonable, although Alice may not be responsible for all of the fall in patent lawsuit filing. For example, Patent Trial and Appeal Board proceedings have become amazingly popular in the past year. The prospect of a having a patent challenged at the PTAB would make anyone holding a less-than-strong patent think twice about using it to suing for infringement.

Three months of the year remain. They should reveal much about whether Alice has caused a temporary pause while patent owners digest Alice and its ramifications or has brought about a more profound change in the filing of patent lawsuits in the US.

If the effect is long term, this could have other impacts. For instance, it could make it harder for those pushing reform in Congress to claim statistics show that patent lawsuits are going through the roof.




more from across site and ros bottom lb

More from across our site

The former head of life sciences at Kramer Levin has joined Orrick, a firm that hopes to grow in the sector
Lionel Martin of August Debouzy and Kristof Neefs at Inteo share how they prevailed in a UPC Court of Appeal case surrounding access to documents
Counsel say ‘strange’ results have increased their reliance on subscription-based search platforms, but costs are not being shifted onto clients yet
The firm was among multiple winners at a record-breaking 2024 ceremony held in London on April 11
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
The Americas research cycle has commenced. Do not miss this opportunity to nominate your work!
Increased and new patent fees could affect prosecution strategies for law firms and companies, according to sources
Five former Oblon lawyers felt that joining Merchant & Gould would help them offer the right prices to entice clients
The UK may not be a UPC member but its firms are still acting in proceedings, with Carpmaels among the most prominent
Naomi Pearce of Pearce IP shares how she is helping her firm become a life sciences leader and how generous policies have helped attract top talent
Gift this article